What else was in the news today?

Today’s news contained items that run the spectrum from the clinical value of tomatoes and lycopene via the cardiovascular side effects of LHRH agonists and antagonists to the question of whether proton beam radiation therapy is really cost-effective. So here are the “news shorts” for the day: … READ MORE …

Lancet comments on PBRT in treatment of prostate cancer

On June 5 we had noted that, the day before, the American Society for Radiation Oncology (ASTRO) released its model policy on the use of proton beam radiation therapy (PBRT) and related reimbursement issues. … READ MORE …

NHS to build two PBRT centers in the UK

Apparently the British National Health Service has decided to stump up £250 million (equivalent to US$380 million) to build two proton beam radiation therapy (PBRT) units in the UK. … READ MORE …

PBRT to come to UK … but not for prostate cancer?

Apparently the powers that be in the UK have decided to shell out the money to build two (small) proton beam radiation therapy (PBRT) units in the UK — one in London and one in Manchester. The media coverage suggests that they will be used primarily for the treatment of rare cancers in children. The centers are scheduled to come on line in 2017. … READ MORE …

ASTRO committee issues evidence-based report on applicability of PBRT

People have strong views about the clinical use of proton beam radiation therapy (PBRT) in the management of localized prostate cancer. The Emerging Technology Committee of the American Society of Radiation Oncology (ASTRO) has now published a report of the applicability of PBRT in many forms of cancer, including prostate cancer. … READ MORE …

PBRT and prostate cancer: your breakfast read on Bloomberg.com

Ye of faith … and ye of rather less faith … in the merits of proton beam radiation therapy (PBRT) compared to other forms of treatment for management of localized prostate cancer may want to read through Robert Langreth’s article (“Prostate cancer therapy too good to be true explodes health cost“) posted this morning on the Bloomberg.com web site. … READ MORE …

Who actually funds research with results that are this obvious?

According to a recently published research letter, men with prostate cancer who live close to the Loma Linda proton beam radiation therapy (PBRT) center are five times more likely to choose PBRT for their treatment than are other men who live in California but don’t live close to Loma Linda! DUH! … READ MORE …